Gilead Sciences, Inc. (GILD) reported mixed Q2 results, which seems to have been received positively by the market as the company's shares are trading higher. This indicates that the positive aspects of the results may have outweighed any negative aspects, leading to increased investor confidence and a rise in the share price.